Oncology company developing proprietary injectable imaging agents for image-guided interventions
Oncology company developing proprietary injectable imaging agents for image-guided interventions. Its platform illuminates tumors during preoperative planning and in the operating room, helping surgeons target tumors while preserving healthy tissue; the agents are reported to last longer than alternatives that require repeated injections.